Cargando…
The Estrogen-Related Receptor α Inverse Agonist XCT 790 Is a Nanomolar Mitochondrial Uncoupler
[Image: see text] XCT 790 is widely used to inhibit estrogen-related receptor α (ERRα) activity as an inverse agonist. Here, we report that XCT 790 potently activates AMP kinase (AMPK) in a dose-dependent and ERRα-independent manner, with active concentrations more than 25-fold below those typically...
Autores principales: | Eskiocak, Banu, Ali, Aktar, White, Michael A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4116149/ https://www.ncbi.nlm.nih.gov/pubmed/24999922 http://dx.doi.org/10.1021/bi500737n |
Ejemplares similares
-
Gemcitabine and XCT790, an ERRα inverse agonist, display a synergistic anticancer effect in pancreatic cancer
por: Liu, Shi-lei, et al.
Publicado: (2022) -
Novel endocrine therapeutic strategy in endometrial carcinoma targeting estrogen-related receptor α by XCT790 and siRNA
por: Sun, PengMing, et al.
Publicado: (2018) -
Bisphenol A at Low Nanomolar Doses Confers Chemoresistance in Estrogen Receptor-α–Positive and –Negative Breast Cancer Cells
por: LaPensee, Elizabeth W., et al.
Publicado: (2009) -
Exploring the binding mode and thermodynamics of inverse agonists against estrogen-related receptor alpha
por: Karnati, Konda Reddy, et al.
Publicado: (2020) -
Uncoupling of ATP-Mediated Calcium Signaling and Dysregulated Interleukin-6 Secretion
in Dendritic Cells by Nanomolar Thimerosal
por: Goth, Samuel R., et al.
Publicado: (2006)